JP2006513165A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513165A5
JP2006513165A5 JP2004552028A JP2004552028A JP2006513165A5 JP 2006513165 A5 JP2006513165 A5 JP 2006513165A5 JP 2004552028 A JP2004552028 A JP 2004552028A JP 2004552028 A JP2004552028 A JP 2004552028A JP 2006513165 A5 JP2006513165 A5 JP 2006513165A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004552028A
Other versions
JP2006513165A (ja
Filing date
Publication date
Priority claimed from US10/290,443 external-priority patent/US7345051B2/en
Application filed filed Critical
Publication of JP2006513165A publication Critical patent/JP2006513165A/ja
Publication of JP2006513165A5 publication Critical patent/JP2006513165A5/ja
Pending legal-status Critical Current

Links

JP2004552028A 2002-11-08 2003-11-10 ムチン合成インヒビター Pending JP2006513165A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/290,443 US7345051B2 (en) 2000-01-31 2002-11-08 Mucin synthesis inhibitors
PCT/US2003/035864 WO2004043392A2 (en) 2002-11-08 2003-11-10 Mucin synthesis inhibitors

Publications (2)

Publication Number Publication Date
JP2006513165A JP2006513165A (ja) 2006-04-20
JP2006513165A5 true JP2006513165A5 (ja) 2006-09-28

Family

ID=32312112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004552028A Pending JP2006513165A (ja) 2002-11-08 2003-11-10 ムチン合成インヒビター

Country Status (6)

Country Link
US (1) US7345051B2 (ja)
EP (1) EP1562903A4 (ja)
JP (1) JP2006513165A (ja)
AU (1) AU2003287621A1 (ja)
CA (1) CA2505557A1 (ja)
WO (1) WO2004043392A2 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178440A1 (en) * 2004-03-19 2007-08-02 Wyeth Inhibitors of gob-4 protein as asthma therapeutics
WO2006066968A1 (en) 2004-12-23 2006-06-29 Glaxo Group Limited Pyridine compounds for the treatment of prostaglandin mediated diseases
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
EP2727910B1 (en) 2007-09-21 2016-03-16 Array Biopharma, Inc. Pyridin-2-yl-thiourea and Pyridin-2-yl-amine derivatives as intermediates for the preparation of Pyridin-2yl-amino-1,2,4-thiadiazole glucokinase activators
AU2008310734B2 (en) 2007-10-10 2014-06-05 Parion Sciences, Inc. Delivering osmolytes by nasal cannula
KR20160129109A (ko) 2008-05-23 2016-11-08 아미라 파마슈티칼스 인코포레이티드 5-리폭시게나아제 활성화 단백질 억제제
WO2012134965A1 (en) * 2011-03-25 2012-10-04 The Trustees Of Columbia University In The City Of New York Chloride channel and chloride transporter modulators for therapy in smooth muscle diseases
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
WO2012170677A1 (en) 2011-06-07 2012-12-13 Parion Sciences, Inc. Methods of treatment
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
BR112014029329A2 (pt) 2012-05-29 2017-06-27 Parion Sciences Inc aminoamidas semelhantes ao dendrímero possuindo atividade bloqueadora de canal de sódio para o tratamento de olho seco e outras doenças mucosais
AU2013363215B2 (en) 2012-12-17 2018-03-01 Parion Sciences, Inc. 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
ES2674665T3 (es) 2012-12-17 2018-07-03 Parion Sciences, Inc. Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
EP3150585A1 (en) 2012-12-17 2017-04-05 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
ES2901114T3 (es) 2014-08-29 2022-03-21 Tes Pharma S R L Inhibidores de ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa
EP3681885B1 (en) 2017-09-15 2024-02-28 Forma Therapeutics, Inc. Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitors
MX2023013508A (es) 2018-06-29 2023-12-13 Forma Therapeutics Inc Inhibicion de la proteina de union a creb (cbp).
EP3797783A1 (en) 2019-09-27 2021-03-31 Freie Universität Berlin Novel medical uses of thiol-functionalized polyglycerol derivatives
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
US3144387A (en) * 1961-06-30 1964-08-11 Parke Davis & Co Anti-inflammatory compositions
AR209858A1 (es) * 1977-02-11 1977-05-31 Bago Sa Labor Procedimiento para la obtencion de 2-(3'trifluormetil anilino)-piridin-3-carboxilato de ftalidilo y sus sales
US4168313A (en) * 1978-02-21 1979-09-18 Sebastian Bago Phthalidyl 2-(3'-trifluoromethyl-anilino)-pyridine-3-carboxylate and its salts
DE2928546A1 (de) * 1979-07-14 1981-01-29 Bago Sa Labor Verfahren zur herstellung von alkylund arylestern von 3'-substituierten und 2',3'-disubstituierten 2-anilino-3-pyridincarbonsaeuren
US4515980A (en) * 1983-07-11 1985-05-07 Sterling Drug Inc. Substituted aminobenzoates, their preparation and use
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4666716A (en) 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
DE3682136D1 (de) * 1985-07-31 1991-11-28 Hoechst Ag N-substituierte 5-nitroanthranilsaeuren, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DE3608726A1 (de) * 1986-03-15 1987-09-17 Hoechst Ag Verwendung aminosubstituierter benzoesaeuren als heilmittel gegen diarrhoe und arzneimittel auf basis dieser verbindungen
US4931459A (en) * 1987-07-14 1990-06-05 Warner-Lambert Company Method for treating acute respirator distress syndrome
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
US5066668A (en) * 1989-06-09 1991-11-19 Warner-Lambert Co. Triazole derivatives of fenamates as antiinflammatory agents
US5114958A (en) * 1991-05-09 1992-05-19 Warner-Lambert Company 1,2,4-oxadiazole and 1,2,4-thiadiazole derivatives of fenamates as antiinflammatory agents
US5143929A (en) * 1991-05-09 1992-09-01 Warner-Lambert Company 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents
US5212189A (en) * 1991-12-17 1993-05-18 Warner-Lambert Company Thiadiazole or oxadiazole analogs of fenamic acids containing substituted hydroxamate side chains as antiinflammatory agents
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
JPH07316075A (ja) * 1994-05-26 1995-12-05 Pola Chem Ind Inc 皮膚外用剤
WO1996039419A1 (en) 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins
WO1997003659A1 (de) 1995-07-20 1997-02-06 Uwe Juergens Verwendung eines nicht-steroidalen antiphlogistikums zur topischen und systemischen behandlung der akuten und chronischen polypoiden rhinosinusitis
US5908839A (en) * 1995-08-24 1999-06-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US5875776A (en) * 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
SI0964865T1 (en) 1997-01-08 2003-08-31 Pharmacia & Upjohn Company Pharmaceutically active tricyclic amines
US6251943B1 (en) 1997-02-28 2001-06-26 Warner-Lambert Company Method of treating or preventing septic shock by administering a MEK inhibitor
EP0993437B1 (en) 1997-07-01 2006-11-08 Warner-Lambert Company Llc 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
WO1999044620A1 (en) 1998-03-03 1999-09-10 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
ATE292462T1 (de) 1999-01-07 2005-04-15 Warner Lambert Co Behandlung von asthma anhand von mek-inhibitoren
ES2252996T3 (es) 1999-01-13 2006-05-16 Warner-Lambert Company Llc Derivados de bencenosulfonamida y su uso como inhibidores de mek.
SK9822001A3 (en) 1999-01-13 2002-08-06 Warner Lambert Co 1-heterocycle substituted diarylamines, pharmaceutical compositions based thereon and their use in therapy
WO2001022935A1 (en) 1999-09-27 2001-04-05 Oh Jun Suk Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same
US20020165244A1 (en) * 2000-01-31 2002-11-07 Yuhong Zhou Mucin synthesis inhibitors
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
CA2398642A1 (en) * 2000-01-31 2001-08-02 Yuhong Zhou Mucin synthesis inhibitors
GB2362101A (en) 2000-05-12 2001-11-14 Astrazeneca Ab Treatment of chronic obstructive pulmonary disease
WO2004113286A2 (en) * 2003-06-19 2004-12-29 Genaera Corporation Mucin synthesis inhibitors

Similar Documents

Publication Publication Date Title
BE2015C007I2 (ja)
BE2014C055I2 (ja)
BE2014C027I2 (ja)
BE2014C003I2 (ja)
BE2013C075I2 (ja)
BE2013C070I2 (ja)
BE2013C036I2 (ja)
JP2003303134A5 (ja)
JP2004005650A5 (ja)
JP2003301950A5 (ja)
BE2015C005I2 (ja)
JP2004228323A5 (ja)
JP2006513165A5 (ja)
JP2003346475A5 (ja)
JP2004168022A5 (ja)
JP2004107094A5 (ja)
JP2004152767A5 (ja)
JP2004227736A5 (ja)
JP2004215874A5 (ja)
JP2004126509A5 (ja)
JP2004220419A5 (ja)
JP2004098168A5 (ja)
AU2002249912A1 (ja)
AU2002332887A1 (ja)
AU2002239060A1 (ja)